DexCom, Inc. DXCM
86.62
(0.85)
(0.97%)
as of 25 Sep
- Market cap
- $33.0B
- P/E
- 33.4×
Follow DXCM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
DexCom, Inc. (DXCM) Book value per share
DexCom, Inc.'s book value per share at the end of fiscal 2025 was 7.0×, up 31.7% from 5.3× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 6.9×. Over the past ten years it has ranged from 0.7× (fiscal 2015) to 7.0× (fiscal 2025) — the current reading is the highest in ten years. DexCom, Inc. ranks 42nd of 149 Medical Devices companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 7.0× | 31.74% |
| FY2024 | 5.3× | (0.32%) |
| FY2023 | 5.4× | (2.11%) |
| FY2022 | 5.5× | 3.72% |
| FY2021 | 5.3× | 9.09% |
| FY2020 | 4.8× | 99.76% |
| FY2019 | 2.4× | 28.83% |
| FY2018 | 1.9× | 54.75% |
| FY2017 | 1.2× | 43.15% |
| FY2016 | 0.8× | 22.47% |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 6.9× | (10.67%) |
| Mar 2026 | 7.7× | 9.11% |
| Dec 2025 | 7.0× | 0.96% |
| Sep 2025 | 7.0× | 6.22% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.7×
High 7.0×
Ten-year median
4.8×
Current reading's percentile
100
Book value per share against peers
| Company | Book value per share |
|---|---|
| STE STERIS plc compare | 74.0× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 65.7× |
| PEN Penumbra, Inc. compare | 38.9× |
| GEHC GE HealthCare Technologies Inc. compare | 24.3× |
| EW Edwards Lifesciences Corporation compare | 18.6× |
| BSX Boston Scientific Corporation compare | 17.1× |
| PHG Koninklijke Philips N.V. compare | 14.0× |
| DXCM DexCom, Inc. | 6.9× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on DXCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement